Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Intravenous Solutions Market
Intravenous Solutions Market size was valued at USD 13 billion in 2023 and is expected to grow at a CAGR of 7.5% over the analysis period, driven by factors such as the growing geriatric population, increasing cases of malnutrition, and high prevalence of preterm births.
Also, increase in the prevalence of diseases, such as neurological conditions, gastrointestinal diseases, and cancer where intravenous solutions serve as the primary sources of energy for patients, is driving the market growth. For instance, as reported by the World Health Organization, global cancer incidence, measured in cases per year, reached approximately 20 million in 2022 and is projected to rise to 35 million by 2050. Thereby, increasing prevalence of such diseases increases the demand for intravenous solutions.
Intravenous (IV) solutions, also known as intravenous fluids or IV fluids, are sterile liquids that are administered directly into the bloodstream via a vein. These solutions are used to provide hydration, deliver medications, maintain electrolyte balance, and supply nutrients to patients who are unable to take fluids or medications orally.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Intravenous Solutions Market Size in 2023: | USD 13 Billion |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 7.5% |
2024 – 2032 Value Projection: | USD 24.8 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 180 |
Tables, Charts & Figures: | 310 |
Segments covered: | Type, Composition, Age Group, Application, End-user, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|